University of Colorado Cancer Center-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2009

  1. Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts

    Molecular Cancer Therapeutics, Vol. 8, Núm. 6, pp. 1484-1493